, ,
This gadget loads the event details dynamically via code in global javascript. Do not remove.

A novel diagnostic tool to solve a large unmet need in a global agricultural industry. CPH – SPRINGBOARD®

  • 10 Mar 2020
  • 14:00 - 17:00
  • Biopeople – Denmark’s Life Science Cluster, kl 14:00 til 17:00 pa Panum - Blegdamsvej 3B, 15 etage 2100 København Ø
  • 12

Registration

  • Sidste tilmeldingsfrist er: Fredag den 28. februar 2020
  • Sidste tilmeldingsfrist er: Fredag den 28. februar 2020

Registration is closed


(Den 20 min. præsentation afholdes på engelsk, men resten er på dansk)

Fokus: forretningsudvikling

Punkter til sparring

Der ønskes sparring og input på følgende områder:

- Go-to-market strategy. How to select the best sales and marketing channel?

- What are the unique and unexpected challenges of selling to farm owners, operators, veterinarians?

- Are we focusing on the right customers?

- Partnering strategy. How to structure agreements with partners/suppliers?

- Have we chosen the relevant segmentation and best pricing strategy?


Branche: Agro, Agroindustri, Medtech

Udviklingsstadie: Proof of Concept


Dated diagnostic practices result in incorrect infection treatment with antibiotics of dairy cattle upwards of 50% of the time. The company has developed a novel diagnostic method based on newly discovered chemistry that enables a comprehensive and cost-effective diagnostic tool to reduce incorrect treatment.

The underlying technology allows an unprecedented flexibility in design of analyses (using DNA and non-DNA based biomarkers) and a 10x reduction in analysis time. The technique is particularly suited to working in remote locations where laboratory level cleanliness cannot be achieved, f.ex. on-farm.

The technology allows the company to bring the most recent advances from human medicine to the industrial veterinary practice.

The company’s first product targets the dairy industry. Incorrect usage of antibiotics alone results in net losses of 10 mio. DKK just in Denmark. The first goal of the company is to eliminate these losses. Worldwide, the first indication/commercial application is 6.7 Billion DKK problem.


Kompetencer

B2B

B2C

Distributionskanaler

Forretningsmodeller

Forretningsudvikling

Partnerskaber

Prissætning

Salg

Strategi og vækstplaner

______________________________________________

Problem

Dated diagnostic practices result in incorrect infection treatment with antibiotics of dairy cattle upwards of 50% of the time.

Solution

The company is developing a point-of-care solution based on newly discovered chemistry that enables a comprehensive and cost effective diagnostic tool to reduce incorrect treatment.

Opportunity

The first indication represents a 1.5 MUSD problem to the Danish Dairy Industry and a 1 Billion USD problem to the global dairy industry. Potential for growth is in adjacent applications, as the dairy industry itself is facing fundamental challenges and stagnant growth.

Business Model, Competition

The companies pricing is focused on savings generated by reduction of unnecessary treatments. The target customers are farm owners/operators.

Potential competition comes from established diagnostics companies (e.g. IDEXX), service laboratories (e.g. EuroFinns) and a variety of smaller diagnostics companies who are either openly working on the problem or are potential entrants.

Team

The team consists of two senior researchers that have been developing the technology over the course of 6 years and are both recognized as leaders in the field. A third member of the team brings the commercial profile having worked in Business Development for a large Danish biotech and as an entrepreneur.

Current financing

The project is funded by InnovationsFonden Denmark until Oct. 2020. A formal fundraising process is to be initiated at the end of January 2020, to which the Go-to-market and partnering strategy are critical.

Status of Technology

The production process for generating an assay is well established and documented. The company is working on a new “panel” specifically for the first commercial application and this is in late Proof-of-Concept stage.

Spørgsmål til panelet

Der ønskes sparring og input på følgende områder:

- Go-to-market strategy. How to select the best sales and marketing channel?

- What are the unique and unexpected challenges of selling to farm owners, operators, veterinarians?

- Are we focusing on the right customers?

- Partnering strategy. How to structure agreements with partners/suppliers?

- Have we chosen the relevant segmentation and best pricing strategy?


CONNECT Denmark — Bryghusgade 8, 1473 København K — Telefon: +45 24 27 07 07 — E-mail: connect@connectdenmark.com — Sociale platforme:
Powered by Wild Apricot Membership Software